AnnMarie DiGiacomo
AnnMarie DiGiacomo is an Associate Director in Strategic Delivery & Growth, Infectious Disease and Critical Care Medicine. She is based in San Diego, California. AnnMarie has more than 25 years of clinical research experience including in academia, biotech/pharmaceutical and the CRO industry. Her expertise focuses on planning and execution of Infectious Disease, Vaccines and Critical Care with experience in clinical development from first in human to registration. She has held regional and global positions of increasing responsibility in program delivery, with primary focus in Interstitial Lung Disease (ILD) and more recently, COVID-19 trials. AnnMarie has provided significant contribution to the FDA approval of treatment for patients with Idiopathic Pulmonary Fibrosis.
AnnMarie earned her bachelor’s degree in biology from the University of Southern California. She joined our company in 2003.
